Potential Therapeutic Targets for Multiple Sclerosis Identified at MD Anderson

Stuart SchlossmanMS Research Study and Reports

Jan 27, 2016  | Carolina Henriques

A study conducted by
researchers at The University of Texas MD Anderson Cancer Center
identified a protein regulator called Trabid as a key player on the
complex chain of events that lead to autoimmune inflammation of the central
nervous system (CNS) in patients with multiple sclerosis (MS). The study,
“Epigenetic regulation of the expression of Il12 and […]










                                            ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

MS Views and News 

helps to provide educational information for persons affected by MS
Keep current with Multiple Sclerosis news and information 
by opting-in to our website: click here – thank you
.===================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews